Showing results (171-180 of 198) with videos related to
Sort By:
Pageof 20
Journal of the European Academy of Dermatology and Venereology : JEADV|January 26, 2017
French updated recommendations in Stage I to III melanoma treatment and managementB Guillot, S Dalac, M G Denis, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 28, 2023
Effectiveness of mogamulizumab in patients with Mycosis Fungoides or Sézary syndrome: A multicentre, retrospective, real-world French studyM Beylot-Barry, G Quereux, C Nardin, et al.British Journal of Pharmacology|June 16, 1999
Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptorsH Okawa, B Nicol, R Bigoni, et al.British Journal of Anaesthesia|February 15, 2015
Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligandsM F Bird, R S Vardanyan, V J Hruby, et al.Annales De Dermatologie Et De Venereologie|March 31, 2000
[Melanoma in organ transplant patients]L Lévêque, S Dalac, A Dompmartin, et al.Annales De Dermatologie Et De Venereologie|October 5, 2019
[Creation, implementation and objectives of CARADERM, a national network for rare skin carcinomas - Adnexal neoplasm part]A Seris, M Battistella, M Beylot-Barry, et al.British Journal of Pharmacology|July 26, 2012
[Dmt1]N/OFQ(1-13)-NH2: a potent nociceptin/orphanin FQ and opioid receptor universal agonistS Molinari, V Camarda, A Rizzi, et al.Neuropharmacology|August 8, 2001
Neuroprotective efficacy of AR-A008055, a clomethiazole analogue, in a global model of acute ischaemic stroke and its effect on ischaemia-induced glutamate and GABA efflux in vitroR M Nelson, A H Hainsworth, D G Lambert, et al.British Journal of Pharmacology|June 7, 2014
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivativesA Rizzi, D Malfacini, M C Cerlesi, et al.Journal of Medicinal Chemistry|November 2, 2001
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptorR Guerrini, G Caló, R Bigoni, et al.Pageof 20